DGCI to approve Covaxin for children between 2-18 years after evaluation of data

Drugs Controller General of India will provide approval for Covaxin for children between 2 and18 years only after evaluation of data, official sources said.

[Via]
Total
0
Shares

Sign Up for NextBigWhat Newsletter

Daily.